Standout Papers
- Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. (1999)
- Current state of immunotherapy for glioblastoma (2018)
- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma (2020)
- Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy (2015)
- Mechanisms of immunotherapy resistance: lessons from glioblastoma (2019)
- Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma (2013)
- Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143 (2017)
- Glioma (2024)
Immediate Impact
185 by Nobel laureates 10 from Science/Nature 215 standout
Citing Papers
Glioblastoma and Other Primary Brain Malignancies in Adults
2023 Standout
Primary brain tumours in adults
2023 Standout
Works of Michael Lim being referenced
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
2020 Standout
Current state of immunotherapy for glioblastoma
2018 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael Lim | 5186 | 5300 | 1806 | 4231 | 381 | 16.5k | |
| Matthias Preusser | 6667 | 6329 | 2513 | 1646 | 532 | 17.8k | |
| James J. Vredenburgh | 8041 | 4621 | 1752 | 1797 | 265 | 14.9k | |
| Ian A. Cree | 4027 | 4695 | 1533 | 1260 | 227 | 16.4k | |
| Santosh Kesari | 5774 | 4177 | 1255 | 1437 | 429 | 17.6k | |
| Allan H. Friedman | 11984 | 5537 | 5050 | 3237 | 340 | 25.2k | |
| Kevin Camphausen | 2899 | 5166 | 632 | 2517 | 321 | 14.2k | |
| Howard A. Fine | 9264 | 5041 | 1942 | 1564 | 231 | 20.5k | |
| Mark R. Gilbert | 14723 | 5722 | 2577 | 2334 | 482 | 24.1k | |
| Christine Marosi | 14391 | 4415 | 1902 | 2334 | 193 | 23.8k | |
| Kenneth Aldape | 10822 | 6478 | 2336 | 3180 | 360 | 26.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...